Michael A. Levesque

2.3k citations
37 papers · 1.8k · 1 hit paper · h-index 22

Impact in

    • Breast Cancer Treatment Studies
  • Genetics top 5%
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema

Papers in

    • Coagulation, Bradykinin, Polyphosphates, and Angioedema 7
    • Cancer, Lipids, and Metabolism 4

Michael A. Levesque

36 papers receiving 1.8k citations

Michael A. Levesque's Hit Papers

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial 2022 · 210 citations
2100+1+2Years since publication50100150200

Peers

Michael A. Levesque
Comparison fields: 5 of 89
  • Cancer Research 469
  • Genetics 289
  • Oncology 482
  • Pulmonary and Respiratory Medicine 467
  • Reproductive Medicine 101
Replace Ioannis A. Voutsadakis with:
Ioannis A. Voutsadakis Canada
Scott N. Holden United States
Kristi A. Boehm United States
John F. Sandbach United States
Virginia E. Kwitkowski United States
Susan E. Sartorius United States
Aristidis Polyzos Greece
Stephen R.D. Johnston United Kingdom
G. Deplanque France
Tatsu Shimoyama Japan
Michael A. Levesque relative to Ioannis A. Voutsadakis Canada Ioannis A. Voutsadakis's profile →
Citations per field
00.5×2×3×3.7×
Ioannis A. Voutsadakis · 1×
Citations per year

Countries citing papers authored by Michael A. Levesque

Since Specialization
Citations

This map shows the geographic impact of Michael A. Levesque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Levesque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Levesque more than expected).

Fields of papers citing papers by Michael A. Levesque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Levesque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Levesque. The network helps show where Michael A. Levesque may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael A. Levesque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael A. Levesque Line = papers co-authored together Michael A. Levesque links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019309
2
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2022210
3
Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
1995162
4 1995118
5 1995111
6 199692
7 200572
8 200559
9 199856
10 200556
11
Expression of the prostate-specific antigen gene by a primary ovarian carcinoma.
199555
12 200053
13 199948
14 200646
15 200142
16 200539
17 200139
18 200631
19 199531
20
Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients.
199931

About Michael A. Levesque

Michael A. Levesque is a scholar working on Genetics, Cancer Research, Oncology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Prostate Cancer Treatment and Research (7 papers), Cancer Research and Treatments (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Cancer, Lipids, and Metabolism (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Renin-Angiotensin System Studies (2 papers). The work is most often cited by research in Cancer Research (469 citations), Genetics (289 citations), Oncology (482 citations), Pulmonary and Respiratory Medicine (467 citations) and Reproductive Medicine (101 citations). Michael A. Levesque has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Eleftherios P. Diamandis, He Yu, P Sismondi, Dionyssios Katsaros, Mario D’Costa, Riccardo Ponzone, Riccardo Roagna, Donald J. A. Sutherland, David M. Goldberg and George J. Soleas. Their work appears in journals such as International Journal of Cancer, Breast Cancer Research and Treatment, Journal of Clinical Laboratory Analysis, Clinical Chemistry and Clinical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact